Entry into the Medical, Welfare, Nursing Care and Digital Marketing Sectors through a Share Exchange with ゼロメディカル
First written in FY2024-Q2. 1 of 3 entries say "Achieved", first in FY2024-Q3. Latest entry: FY2025.
0 other companies' latest entry also says "Dropped".
- FY2025DroppedAnnual report
「As of 30 May 2025, all shares held by the company had been sold, and the business was discontinued effective 12 June of the same year.」
The company's entry into the medical, welfare, care and digital marketing sectors through ゼロメディカル becoming a wholly owned subsidiary ended with the sale of all shares on 30 May 2025 and the discontinuation of the medical business on 12 June. - FY2024-Q3AchievedAnnual report
「The Company entered into a share exchange agreement with ゼロメディカル Co., Ltd. (head office: 1-5-4 Higashiyama, Meguro-ku, Tokyo; representative director: Hara Masahiro (原 征弘); hereinafter, “ゼロメディカル”), which promotes businesses primarily aimed at resolving social issues relating to “health” and “welfare,” under which the Company would be the wholly owning parent company resulting from the share exchange and ゼロメディカル would be the wholly owned subsidiary resulting from the share exchange. ゼロメディカル became a wholly owned subsidiary on the effective date, 1 December 2023.」
The planned share exchange with ゼロメディカル from the previous quarter was completed, making it a wholly owned subsidiary effective 1 December 2023. The consideration delivered consisted of 1,625,000 treasury shares and ¥375 million in cash. - FY2024-Q2First statedAnnual report
「At a meeting of the Board of Directors held on 26 October 2023, we resolved to conduct a share exchange with ゼロメディカル Co., Ltd. (hereinafter, "ゼロメディカル"), under which our company would become the wholly owning parent company in the share exchange and ゼロメディカル would become the wholly owned subsidiary in the share exchange, and we entered into a share exchange agreement between the two companies. With respect to our company, the share exchange is scheduled to take effect on 1 December 2023 through the simplified share exchange procedure, which does not require shareholder approval under Article 796, paragraph 2 of the Companies Act.」
The company first disclosed its plan to bring ゼロメディカル's medical, welfare and care consulting, website development, planning and operation businesses into the group as a wholly owned subsidiary with 100% voting rights through a share exchange. As consideration, it planned to deliver 1,625,000 common shares of the company and ¥375 million in cash, with the aim of expanding its business share and creating new revenue opportunities by leveraging the two companies' respective transaction networks, human resources and business expertise.